Linden Advisors’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-450,000
| Closed | -$4.54M | – | 566 |
|
|
2022
Q4 | $4.54M | Hold |
450,000
| – | – | 0.05% | 216 |
|
|
2022
Q3 | $4.46M | Hold |
450,000
| – | – | 0.04% | 240 |
|
|
2022
Q2 | $4.41M | Hold |
450,000
| – | – | 0.04% | 262 |
|
|
2022
Q1 | $4.41M | Hold |
450,000
| – | – | 0.03% | 353 |
|
|
2021
Q4 | $4.37M | Hold |
450,000
| – | – | 0.03% | 331 |
|
|
2021
Q3 | $4.36M | Hold |
450,000
| – | – | 0.03% | 331 |
|
|
2021
Q2 | $4.35M | Buy |
+450,000
| New | +$4.35M | 0.02% | 361 |
|